Bosentan treatment results in sustained improvement of endothelial dysfunction in patients with Systemic Sclerosis: A controlled, two-month, prospective study

被引：0
|
作者：
Papamichael, C
Fragiadaki, KG
Stamatelopoulos, K
Katsichti, V
Mavrikakis, M
Sfikakis, PP
机构：
[1] Univ Athens, Sch Med, Dept Therapeut, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Prop Internal Med 1, GR-11527 Athens, Greece
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S631 / S632
页数：2
相关论文
共 50 条
  • [31] Endovascular treatment of chronic cerebro spinal venous insufficiency in patients with multiple sclerosis modifies circulating markers of endothelial dysfunction and coagulation activation: a prospective study
    Napolitano, Mariasanta
    Bruno, Aldo
    Mastrangelo, Diego
    De Vizia, Marcella
    Bernardo, Benedetto
    Buonagura, Rosa
    De Lucia, Domenico
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (07) : 716 - 720
  • [32] Endothelial markers in systemic sclerosis. Effect of beraprost sodium. Results of a double-blind controlled study.
    Vayssairat, M
    [J]. JOURNAL OF VASCULAR RESEARCH, 1998, 35 : 11 - 11
  • [33] Long-term integrated treatment with bosentan and iloprost in systemic sclerosis patients: increase of nailfold absolute capillary number, fingertip blood perfusion and improvement of clinical status
    Trombetta, A. C.
    Pizzorni, C.
    Ruaro, B.
    Paolino, S.
    Sulli, A.
    Smith, V.
    Cutolo, M.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 166 - 166
  • [34] TREATMENT WITH SILYMARIN IN PATIENTS WITH CIRRHOSIS OF THE LIVER - RESULTS OF A CONTROLLED PROSPECTIVE-STUDY AND OF THE POST STUDY SURVEILLANCE
    FERENCI, P
    DRAGOSICS, B
    CSOMOS, G
    SCHNEIDER, B
    [J]. HEPATOLOGY, 1986, 6 (04) : 790 - 790
  • [35] Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo:: Results of a placebo-controlled 12-month prospective study
    Hartmann, Anke
    Broecker, Eva-Bettina
    Hamm, Henning
    [J]. ACTA DERMATO-VENEREOLOGICA, 2008, 88 (05) : 474 - 479
  • [36] Prevalence of sicca symptoms and Sjogren's syndrome in systemic sclerosis: Results of a prospective two-center series of 133 patients
    Avouac, J.
    Sordet, C.
    Depinay, C.
    Ardizonne, M.
    Vacher-Lavenu, M.
    Sibilia, J.
    Kahan, A.
    Allanore, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 382 - 382
  • [37] Effects of prostaglandin E1α cyclodextrin treatment on endothelial dysfunction in patients with systemic sclerosis' (vol 25, pg 793, 2007)
    Giannattasio, C.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (07) : 1523 - 1523
  • [38] Effect of the dual endothelin receptor antagonist bosentan on Raynaud's phenomenon secondary to systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study
    Nguyen, Van Anh
    Eisendle, Klaus
    Gruber, Ingrid
    Hugl, Beate
    Reider, Daniela
    Reider, Norbert
    [J]. RHEUMATOLOGY, 2010, 49 (03) : 583 - 587
  • [39] ULNAR OCCLUSION IS A MARKER OF GLOBAL VASCULAR DAMAGE IN SYSTEMIC SCLEROSIS: RESULTS FROM A MONOCENTRIC PROSPECTIVE STUDY OF 99 PATIENTS
    Yelnik, C. M.
    Elodie, D.
    Lamotte, C.
    Sobanski, V.
    Morell-Dubois, S.
    Maillard, H.
    Lambert, M.
    Hatron, P. -Y.
    Launay, D.
    Hachulla, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1094 - 1094
  • [40] Do patients who seek treatment for overactive bladder get better? Results of a 12 month prospective study
    Basra, R.
    Cortes, E.
    Basra, H.
    Khullar, V
    Kelleher, C.
    [J]. INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 : S53 - S54
12345